Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CARLSMED, INC.CARL · Entity 5551 | Chief Operating Officer | October 05, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CARLSMED, INC.
Report date October 05, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,489 |
Ending reported balance
After 2026-10-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-05 · Exercise / conversion · Acquired 747 · Balance 23,236 Row 2 · 2026-10-05 · Sale · Disposed 747 · Balance 22,489 F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.92 · Expires 2035-04-09 | Direct | 21,655 |
Reported balance
After 2026-10-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-10-05 · Exercise / conversion · Disposed 747 · Balance 21,655 F2: 25% of the original number of shares subject to the stock option vested on March 3, 2026, and the remaining 75% of the original number of shares subject to the stock option will vest in 1/36th installments on a monthly basis thereafter, subject to the Reporting Person's continued service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
F2: 25% of the original number of shares subject to the stock option vested on March 3, 2026, and the remaining 75% of the original number of shares subject to the stock option will vest in 1/36th installments on a monthly basis thereafter, subject to the Reporting Person's continued service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2026 Filed Oct 6, 2026 20:59 UTC | CARLSMED, INC. CARL · Entity 5551 | Exercise / conversionStock Option (Right to Buy) · Derivative | 747 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0001193125-26-415735 · ownership.xml · derivative · entry 3 Bertolini Jeffrey · CIK 0002147819 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,655 Underlying: Common Stock · 747 shares Expires 2035-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the original number of shares subject to the stock option vested on March 3, 2026, and the remaining 75% of the original number of shares subject to the stock option will vest in 1/36th installments on a monthly basis thereafter, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| October 05, 2026 Filed Oct 6, 2026 20:59 UTC | CARLSMED, INC. CARL · Entity 5551 | SaleCommon Stock | 747 | $14.39 | $10,749.33 |
DisclosureSEC source: 0001193125-26-415735 · ownership.xml · nonDerivative · entry 2 Bertolini Jeffrey · CIK 0002147819 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,489 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. Read SEC document |
| October 05, 2026 Filed Oct 6, 2026 20:59 UTC | CARLSMED, INC. CARL · Entity 5551 | Exercise / conversionCommon Stock | 747 | $5.92 | $4,418.51 |
DisclosureSEC source: 0001193125-26-415735 · ownership.xml · nonDerivative · entry 1 Bertolini Jeffrey · CIK 0002147819 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 01:35 UTC | CARLSMED, INC. CARL · Entity 5551 | Exercise / conversionStock Option (Right to Buy) · Derivative | 243 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0001193125-26-410891 · ownership.xml · derivative · entry 3 Bertolini Jeffrey · CIK 0002147819 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,825 Underlying: Common Stock · 243 shares Expires 2034-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the original number of shares subject to the stock option vested on September 30, 2025, and the remaining 75% of the original number of shares subject to the stock option will vest in 1/36th installments on a monthly basis thereafter, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 01:35 UTC | CARLSMED, INC. CARL · Entity 5551 | SaleCommon Stock | 243 | $13.99 | $3,399.57 |
DisclosureSEC source: 0001193125-26-410891 · ownership.xml · nonDerivative · entry 2 Bertolini Jeffrey · CIK 0002147819 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,489 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 01:35 UTC | CARLSMED, INC. CARL · Entity 5551 | Exercise / conversionCommon Stock | 243 | $2.23 | $542.38 |
DisclosureSEC source: 0001193125-26-410891 · ownership.xml · nonDerivative · entry 1 Bertolini Jeffrey · CIK 0002147819 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 22:38 UTC | CARLSMED, INC. CARL · Entity 5551 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $15.23 | $0.00 |
DisclosureSEC source: 0002147819-26-000005 · ownership.xml · derivative · entry 1 Bertolini Jeffrey · CIK 0002147819 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-09-07 F1 · derivative.exercise_date: Includes 50,000 stock options exercisable into approximately 50,000 shares of the Issuer's common stock, which began to vest on September 8, 2026, subject to a one year cliff, and shall vest in equal installments on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.